Corrigendum to 'In vivo antitumour properties of tribenzyltin carboxylates in a 4T1 murine metastatic mammary tumour model: Enhanced efficacy by PLGA nanoparticles' [European Journal of Pharmaceutical Sciences 142 (2020) 105140].

التفاصيل البيبلوغرافية
العنوان: Corrigendum to 'In vivo antitumour properties of tribenzyltin carboxylates in a 4T1 murine metastatic mammary tumour model: Enhanced efficacy by PLGA nanoparticles' [European Journal of Pharmaceutical Sciences 142 (2020) 105140].
المؤلفون: Anasamy T; Department of Pharmacy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia., Chee CF; Nanotechnology and Catalysis Research Centre, University of Malaya, 50603 Kuala Lumpur, Malaysia., Kiew LV; Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia., Chung LY; Department of Pharmacy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia. Electronic address: chungly@um.edu.my.
المصدر: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2023 Feb 01; Vol. 181, pp. 106320. Date of Electronic Publication: 2022 Nov 04.
نوع المنشور: Published Erratum
اللغة: English
بيانات الدورية: Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: PubMed not MEDLINE; MEDLINE
أسماء مطبوعة: Publication: Amsterdam : Elsevier Science B.V
Original Publication: Amsterdam ; New York : Elsevier, c1993-
التعليقات: Erratum for: Eur J Pharm Sci. 2020 Jan 15;142:105140. (PMID: 31704345)
تواريخ الأحداث: Date Created: 20221106 Latest Revision: 20230116
رمز التحديث: 20231215
DOI: 10.1016/j.ejps.2022.106320
PMID: 36336567
قاعدة البيانات: MEDLINE
الوصف
تدمد:1879-0720
DOI:10.1016/j.ejps.2022.106320